The cross-talk between the Hippo signaling pathway and autophagy:implications on physiology and cancer

References

• Stanger BZ. Organ size determination and the limits of regulation. Cell Cycle. 2008;7(3):318–324.
   PubMed Web of Science ®Google Scholar
• Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–450.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330(6009):1344–1348.
   PubMed Web of Science ®Google Scholar
• Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861–2873.
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22(2):124–131.
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12:401.
   PubMed Web of Science ®Google Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–364.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11(9):709–730.
   PubMed Web of Science ®Google Scholar
• Yu F-X, Zhao B, Guan K-L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811–828.
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246.
   PubMed Web of Science ®Google Scholar
• Calses PC, Crawford JJ, Lill JR, et al. Hippo pathway in cancer: aberrant regulation and therapeutic opportunities. Trends Cancer. 2019;5(5):297–307.
   PubMed Web of Science ®Google Scholar
• Lin L, Sabnis AJ, Chan E, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015;47:250.
   PubMed Web of Science ®Google Scholar
• Kim MH, Kim J, Hong H, et al. Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation. Embo J. 2016;35(5):462–478.
   PubMed Web of Science ®Google Scholar
• Moya IM, Halder G. Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20(4):211–226.
   PubMed Web of Science ®Google Scholar
• Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling. Nature. 2019;572(7769):402–406.
   PubMed Web of Science ®Google Scholar
• Diepenbruck M, Christofori G. Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7–13.
   PubMed Web of Science ®Google Scholar
• Yang W-H, Ding C-KC, Sun T, et al. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28(10):2501–8.e4.
   PubMed Web of Science ®Google Scholar
• Ni X, Tao J, Barbi J, et al. YAP is essential for Treg-mediated suppression of antitumor immunity. Cancer Discov. 2018;8(8):1026–1043.
   PubMed Web of Science ®Google Scholar
• Moroishi T, Hayashi T, Pan -W-W, et al. The Hippo pathway Kinases LATS1/2 suppress cancer immunity. Cell. 2016;167(6):1525–39.e17.
   PubMed Web of Science ®Google Scholar
• Tumaneng K, Russell Ryan C, Guan K-L. Organ size control by Hippo and TOR pathways. Curr Biol. 2012;22(9):R368–R79.
   PubMed Web of Science ®Google Scholar
• Wang W, Xiao Z-D, Li X, et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17(4):490–499.
   PubMed Web of Science ®Google Scholar
• Mo J-S, Meng Z, Kim YC, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17(4):500–510.
   PubMed Web of Science ®Google Scholar
• DeRan M, Yang J, Shen C-H, et al. Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9(2):495–503.
   PubMed Web of Science ®Google Scholar
• Hansen CG, Ng YLD, Lam W-LM, et al. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Cell Res. 2015;25(12):1299–1313.
   PubMed Web of Science ®Google Scholar
• Tumaneng K, Schlegelmilch K, Russell RC, et al. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol. 2012;14(12):1322–1329.
   PubMed Web of Science ®Google Scholar
• Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13(9):1016–1023.
   PubMed Web of Science ®Google Scholar
• Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126(5):955–968.
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–226.
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan K-L. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577–590.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein Kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456–461.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim Young C, Fang C, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell. 2013;152(1):290–303.
   PubMed Web of Science ®Google Scholar
• Lee YA, Noon LA, Akat KM, et al. Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Nat Commun. 2018;9(1):4962.
   PubMed Web of Science ®Google Scholar
• Liang N, Zhang C, Dill P, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211(11):2249–2263.
   PubMed Web of Science ®Google Scholar
• Tang F, Gao R, Jeevan-Raj B, et al. LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function. Nat Commun. 2019;10(1):5755.
   PubMedGoogle Scholar
• Wang P, Gong Y, Guo T, et al. Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death Dis. 2019;10(6):432.
   PubMedGoogle Scholar
• Tyra LK, Nandi N, Tracy C, et al. Yorkie growth-promoting activity is limited by Atg1-mediated phosphorylation. Dev Cell. 2020;52(5):605–16.e7.
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747–2761.
   PubMed Web of Science ®Google Scholar
• Totaro A, Zhuang Q, Panciera T, et al. Cell phenotypic plasticity requires autophagic flux driven by YAP/TAZ mechanotransduction. Proc Nat Acad Sci. 2019;116(36):17848–17857.
   PubMed Web of Science ®Google Scholar
• Pavel M, Renna M, Park SJ, et al. Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis. Nat Commun. 2018;9(1):2961.
   PubMed Web of Science ®Google Scholar
• Song Q, Mao B, Cheng J, et al. YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation. Plos One. 2015;10(3):e0120790.
   PubMed Web of Science ®Google Scholar
• Wilkinson Deepti S, Jariwala Jinel S, Anderson E, et al. Phosphorylation of LC3 by the Hippo Kinases STK3/STK4 is essential for autophagy. Mol Cell. 2015;57(1):55–68.
   PubMed Web of Science ®Google Scholar
• Tang F, Zhang L, Xue G, et al. hMOB3 modulates MST1 apoptotic signaling and supports tumor growth in glioblastoma multiforme. Cancer Res. 2014;74(14):3779–3789.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Kyoi S, Zhai P, et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19:1478.
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Wang QJ, Yue Z. The Beclin 1–VPS34 complex – at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20(6):355–362.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Zhai P, Del Re DP, et al. Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. JCI Insight. 2016;1(5). DOI:https://doi.org/10.1172/jci.insight.86217
   Web of Science ®Google Scholar
• Boutouja F, Brinkmeier R, Mastalski T, et al. Regulation of the tumor-suppressor BECLIN 1 by distinct ubiquitination cascades. Int J Mol Sci. 2017;18(12):2541.
   Web of Science ®Google Scholar
• Furth N, Aylon Y. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell Death Differ. 2017;24:1488.
   PubMed Web of Science ®Google Scholar
• Aylon Y, Gershoni A, Rotkopf R, et al. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Genes Dev. 2016;30(7):786–797.
   PubMed Web of Science ®Google Scholar
• Dutta S, Baehrecke EH. Warts is required for PI3K-regulated growth arrest, autophagy, and autophagic cell death in drosophila. Curr Biol. 2008;18(19):1466–1475.
   PubMed Web of Science ®Google Scholar
• Guo B, Huang X, Zhang P, et al. Genome-wide screen identifies signaling pathways that regulate autophagy during Caenorhabditis elegans development. EMBO Rep. 2014;15(6):705–713.
   PubMed Web of Science ®Google Scholar
• Gan W, Dai X, Dai X, et al. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat Cell Biol. 2020;22:246–256.
   PubMed Web of Science ®Google Scholar
• Tang F, Gill J, Ficht X, et al. The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. Sci Signal. 2015;8(397):ra100–ra.
   PubMed Web of Science ®Google Scholar
• Joffre C, Dupont N, Hoa L, et al. The pro-apoptotic STK38 Kinase is a new Beclin1 partner positively regulating autophagy. Curr Biol. 2015;25(19):2479–2492.
   PubMed Web of Science ®Google Scholar
• Martin AP, Jacquemyn M, Lipecka J, et al. STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes. EMBO Rep. 2019;20(11):e48150.
   PubMed Web of Science ®Google Scholar
• Klimek C, Jahnke R, Wördehoff J, et al. The Hippo network kinase STK38 contributes to protein homeostasis by inhibiting BAG3-mediated autophagy. Biochim Biophys Acta Mol Cell Res. 2019;1866(10):1556–1566.
   PubMed Web of Science ®Google Scholar
• Liu J, Kuang F, Kroemer G, et al. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol. 2020;27(4):420–435.
   PubMed Web of Science ®Google Scholar